Annual FCF:
$2.04B-$279.00M(-12.03%)Summary
- As of today, TEVA annual free cash flow is $2.04 billion, with the most recent change of -$279.00 million (-12.03%) on December 31, 2024.
- During the last 3 years, TEVA annual free cash flow has risen by +$156.00 million (+8.28%).
- TEVA annual free cash flow is now -57.23% below its all-time high of $4.77 billion, reached on December 31, 2015.
Performance
TEVA Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly FCF:
-$571.77M-$661.77M(-735.30%)Summary
- As of today, TEVA quarterly free cash flow is -$571.77 million, with the most recent change of -$661.77 million (-735.30%) on June 30, 2025.
- Over the past year, TEVA quarterly free cash flow has dropped by -$894.77 million (-277.02%).
- TEVA quarterly free cash flow is now -130.27% below its all-time high of $1.89 billion, reached on December 31, 2018.
Performance
TEVA Quarterly Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
$1.19B-$894.77M(-42.96%)Summary
- As of today, TEVA TTM free cash flow is $1.19 billion, with the most recent change of -$894.77 million (-42.96%) on June 30, 2025.
- Over the past year, TEVA TTM free cash flow has dropped by -$885.77 million (-42.71%).
- TEVA TTM free cash flow is now -76.90% below its all-time high of $5.14 billion, reached on June 30, 2015.
Performance
TEVA TTM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
TEVA Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -12.0% | -277.0% | -42.7% |
| 3Y3 Years | +8.3% | -302.0% | -35.3% |
| 5Y5 Years | +19.3% | -205.3% | -50.1% |
TEVA Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -12.0% | +8.3% | -138.5% | at low | -56.6% | at low |
| 5Y | 5-Year | -12.0% | +19.3% | -138.5% | at low | -56.6% | at low |
| All-Time | All-Time | -57.2% | +2315.1% | -130.3% | +16.9% | -76.9% | +1768.6% |
TEVA Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$571.77M(-735.3%) | $1.19B(-43.0%) |
| Mar 2025 | - | $90.00M(-88.5%) | $2.08B(+2.1%) |
| Dec 2024 | $2.04B(-12.0%) | $786.00M(-11.1%) | $2.04B(-25.5%) |
| Sep 2024 | - | $884.00M(+173.7%) | $2.74B(+32.1%) |
| Jun 2024 | - | $323.00M(+587.2%) | $2.07B(-10.9%) |
| Mar 2024 | - | $47.00M(-96.8%) | $2.33B(+0.3%) |
| Dec 2023 | $2.32B(+6.3%) | $1.49B(+581.7%) | $2.32B(+18.9%) |
| Sep 2023 | - | $218.00M(-62.2%) | $1.95B(-19.3%) |
| Jun 2023 | - | $576.00M(+1376.9%) | $2.42B(+13.8%) |
| Mar 2023 | - | $39.00M(-96.5%) | $2.12B(-2.7%) |
| Dec 2022 | $2.18B(+15.8%) | $1.12B(+63.5%) | $2.18B(+25.5%) |
| Sep 2022 | - | $683.00M(+141.3%) | $1.74B(-5.3%) |
| Jun 2022 | - | $283.00M(+185.9%) | $1.83B(-11.0%) |
| Mar 2022 | - | $99.00M(-85.3%) | $2.06B(+9.4%) |
| Dec 2021 | $1.88B(-7.8%) | $673.00M(-13.7%) | $1.88B(+12.9%) |
| Sep 2021 | - | $780.00M(+52.9%) | $1.67B(+20.4%) |
| Jun 2021 | - | $510.00M(+745.6%) | $1.39B(-2.3%) |
| Mar 2021 | - | -$79.00M(-117.2%) | $1.42B(-30.5%) |
| Dec 2020 | $2.04B(+19.5%) | $458.00M(-7.8%) | $2.04B(-14.3%) |
| Sep 2020 | - | $497.00M(-8.5%) | $2.38B(-0.9%) |
| Jun 2020 | - | $543.00M(-0.4%) | $2.40B(+26.1%) |
| Mar 2020 | - | $545.00M(-31.7%) | $1.91B(+11.5%) |
| Dec 2019 | $1.71B(-51.6%) | $798.00M(+54.1%) | $1.71B(-39.0%) |
| Sep 2019 | - | $518.00M(+1051.1%) | $2.80B(+75.6%) |
| Jun 2019 | - | $45.00M(-87.1%) | $1.59B(-37.4%) |
| Mar 2019 | - | $349.00M(-81.5%) | $2.55B(-27.9%) |
| Dec 2018 | $3.53B(+34.1%) | $1.89B(+374.6%) | $3.53B(+0.4%) |
| Sep 2018 | - | -$688.00M(-169.1%) | $3.52B(-26.6%) |
| Jun 2018 | - | $996.00M(-25.3%) | $4.79B(+18.7%) |
| Mar 2018 | - | $1.33B(-28.9%) | $4.03B(+53.1%) |
| Dec 2017 | $2.63B(-39.3%) | $1.87B(+221.4%) | $2.63B(+42.2%) |
| Sep 2017 | - | $583.00M(+140.9%) | $1.85B(-26.2%) |
| Jun 2017 | - | $242.00M(+466.7%) | $2.51B(-17.9%) |
| Mar 2017 | - | -$66.00M(-106.0%) | $3.05B(-29.4%) |
| Dec 2016 | $4.34B(-9.0%) | $1.09B(-11.9%) | $4.32B(-6.0%) |
| Sep 2016 | - | $1.24B(+57.4%) | $4.60B(+7.4%) |
| Jun 2016 | - | $788.00M(-34.6%) | $4.28B(-10.9%) |
| Mar 2016 | - | $1.20B(-11.9%) | $4.80B(+0.7%) |
| Dec 2015 | $4.77B(+13.6%) | $1.37B(+48.1%) | $4.77B(-1.8%) |
| Sep 2015 | - | $923.00M(-29.6%) | $4.86B(-5.6%) |
| Jun 2015 | - | $1.31B(+12.1%) | $5.14B(+9.6%) |
| Mar 2015 | - | $1.17B(-19.5%) | $4.69B(+11.8%) |
| Dec 2014 | $4.20B(+90.4%) | $1.45B(+19.8%) | $4.20B(+30.0%) |
| Sep 2014 | - | $1.21B(+40.8%) | $3.23B(+46.5%) |
| Jun 2014 | - | $861.00M(+27.9%) | $2.20B(+9.4%) |
| Mar 2014 | - | $673.00M(+39.5%) | $2.01B(-8.7%) |
| Dec 2013 | $2.21B(-36.2%) | $482.33M(+157.0%) | $2.21B(-25.9%) |
| Sep 2013 | - | $187.70M(-72.0%) | $2.98B(-17.3%) |
| Jun 2013 | - | $671.40M(-22.3%) | $3.60B(-6.7%) |
| Mar 2013 | - | $863.79M(-31.1%) | $3.86B(+11.7%) |
| Dec 2012 | $3.46B | $1.25B(+54.7%) | $3.46B(+4.7%) |
| Sep 2012 | - | $810.61M(-12.8%) | $3.30B(+23.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2012 | - | $930.01M(+101.8%) | $2.66B(-6.3%) |
| Mar 2012 | - | $460.93M(-58.0%) | $2.84B(-7.2%) |
| Dec 2011 | $3.06B(-10.4%) | $1.10B(+524.4%) | $3.06B(+8.1%) |
| Sep 2011 | - | $175.72M(-84.2%) | $2.83B(-22.7%) |
| Jun 2011 | - | $1.11B(+63.1%) | $3.67B(+8.4%) |
| Mar 2011 | - | $680.73M(-21.6%) | $3.38B(-1.2%) |
| Dec 2010 | $3.42B(+29.1%) | $868.43M(-13.7%) | $3.42B(+2.8%) |
| Sep 2010 | - | $1.01B(+22.0%) | $3.33B(+7.0%) |
| Jun 2010 | - | $825.07M(+14.5%) | $3.11B(+11.8%) |
| Mar 2010 | - | $720.42M(-7.2%) | $2.78B(+5.2%) |
| Dec 2009 | $2.65B(+4.4%) | $776.38M(-1.5%) | $2.65B(-7.6%) |
| Sep 2009 | - | $788.25M(+58.5%) | $2.86B(+3.4%) |
| Jun 2009 | - | $497.25M(-14.8%) | $2.77B(-3.9%) |
| Mar 2009 | - | $583.81M(-41.2%) | $2.88B(-0.6%) |
| Dec 2008 | $2.54B(+100.8%) | $992.93M(+43.2%) | $2.90B(+26.4%) |
| Sep 2008 | - | $693.19M(+13.5%) | $2.29B(+27.8%) |
| Jun 2008 | - | $610.69M(+1.8%) | $1.79B(+17.8%) |
| Mar 2008 | - | $600.15M(+54.5%) | $1.52B(+20.4%) |
| Dec 2007 | $1.26B(-23.9%) | $388.34M(+100.3%) | $1.26B(-15.8%) |
| Sep 2007 | - | $193.92M(-42.9%) | $1.50B(-25.1%) |
| Jun 2007 | - | $339.81M(-0.8%) | $2.00B(+12.3%) |
| Mar 2007 | - | $342.45M(-45.2%) | $1.79B(+7.6%) |
| Dec 2006 | $1.66B(+59.8%) | $624.82M(-10.4%) | $1.66B(+37.0%) |
| Sep 2006 | - | $697.54M(+477.0%) | $1.21B(+49.1%) |
| Jun 2006 | - | $120.88M(-44.2%) | $812.31M(-22.5%) |
| Mar 2006 | - | $216.46M(+22.7%) | $1.05B(-1.3%) |
| Dec 2005 | $1.04B(+14.0%) | $176.46M(-40.9%) | $1.06B(-9.5%) |
| Sep 2005 | - | $298.50M(-16.4%) | $1.17B(-1.7%) |
| Jun 2005 | - | $357.16M(+55.3%) | $1.19B(+18.3%) |
| Mar 2005 | - | $230.03M(-20.0%) | $1.01B(+7.5%) |
| Dec 2004 | $910.73M(+128.7%) | $287.54M(-9.8%) | $938.25M(+21.9%) |
| Sep 2004 | - | $318.61M(+84.3%) | $769.97M(+70.6%) |
| Jun 2004 | - | $172.85M(+8.5%) | $451.36M(+62.1%) |
| Mar 2004 | - | $159.24M(+33.5%) | $278.50M(+133.5%) |
| Dec 2003 | $398.26M(+136.5%) | $119.26M(+48.6%) | $119.26M(-39.8%) |
| Dec 2002 | $168.41M(+21.1%) | - | - |
| Jun 2002 | - | $80.25M(+6.2%) | $197.97M(+31.0%) |
| Mar 2002 | - | $75.60M(+938.2%) | $151.09M(+8.6%) |
| Dec 2001 | $139.08M(+159.0%) | $7.28M(-79.1%) | $139.08M(+5.5%) |
| Sep 2001 | - | $34.84M(+4.4%) | $131.80M(+35.9%) |
| Jun 2001 | - | $33.38M(-47.5%) | $96.96M(+52.5%) |
| Mar 2001 | - | $63.59M | $63.59M |
| Dec 2000 | $53.69M(-83.4%) | - | - |
| Dec 1999 | $324.03M(+713.9%) | - | - |
| Dec 1998 | $39.81M(-68.3%) | - | - |
| Dec 1997 | $125.74M(+236.5%) | - | - |
| Dec 1996 | -$92.10M(-410.4%) | - | - |
| Dec 1995 | $29.67M(+190.3%) | - | - |
| Dec 1994 | -$32.85M(-6437.2%) | - | - |
| Dec 1993 | -$502.50K(+64.3%) | - | - |
| Dec 1992 | -$1.41M(+89.3%) | - | - |
| Dec 1991 | -$13.20M | - | - |
FAQ
- What is Teva Pharmaceutical Industries Limited annual free cash flow?
- What is the all-time high annual free cash flow for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited annual free cash flow year-on-year change?
- What is Teva Pharmaceutical Industries Limited quarterly free cash flow?
- What is the all-time high quarterly free cash flow for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited quarterly free cash flow year-on-year change?
- What is Teva Pharmaceutical Industries Limited TTM free cash flow?
- What is the all-time high TTM free cash flow for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited TTM free cash flow year-on-year change?
What is Teva Pharmaceutical Industries Limited annual free cash flow?
The current annual free cash flow of TEVA is $2.04B
What is the all-time high annual free cash flow for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high annual free cash flow is $4.77B
What is Teva Pharmaceutical Industries Limited annual free cash flow year-on-year change?
Over the past year, TEVA annual free cash flow has changed by -$279.00M (-12.03%)
What is Teva Pharmaceutical Industries Limited quarterly free cash flow?
The current quarterly free cash flow of TEVA is -$571.77M
What is the all-time high quarterly free cash flow for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high quarterly free cash flow is $1.89B
What is Teva Pharmaceutical Industries Limited quarterly free cash flow year-on-year change?
Over the past year, TEVA quarterly free cash flow has changed by -$894.77M (-277.02%)
What is Teva Pharmaceutical Industries Limited TTM free cash flow?
The current TTM free cash flow of TEVA is $1.19B
What is the all-time high TTM free cash flow for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high TTM free cash flow is $5.14B
What is Teva Pharmaceutical Industries Limited TTM free cash flow year-on-year change?
Over the past year, TEVA TTM free cash flow has changed by -$885.77M (-42.71%)